Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

Get Premium

Register

Sign In

EUR/USD

1.2277

-0.0005

-0.04%

GBP/USD

1.3911

0.0000

0.00%

USD/JPY

107.37

-0.2025

-0.19%

USD/CHF

0.9392

0.0005

0.05%

EUR/GBP

0.8826

-0.0004

-0.04%

USD/CAD

1.2692

-0.0006

-0.04%

NZD/USD

0.7318

0.0002

0.03%

EUR/JPY

131.82

-0.3055

-0.23%

EUR/CHF

1.1530

0.0002

0.01%

Avinger Inc. Cmn

NASDAQ: AVGRHealthcare / Medical Appliances & Equipment / USA
1.49-0.01-0.67%Vol 296 5341Y Perf -98.45%
Feb 21st, 2018 15:59
BID1.44 ASK1.57
Open1.50 Previous Close1.50
Pre-Market- After-Trading-
 - -%  - -%
Target Price
2.00 
Analyst Rating
Hold 3.00
Potencial %
34.23 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-100/-100 
Income Ranking
 —    -
Market Cap (mil)1 
Earnings Rating
Neutral
Price Range Ratio 52wk %
0.21 
Earnings Date
5th Mar 2018

Today's Price Range

1.391.56

 

52wk Range

1.25117.60

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Buy
Performance
1 Month
645.00%
3 Months
547.83%
6 Months
413.79%
1 Year
-98.45%
3 Years
-85.69%
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
AVGR1.49-0.0100-0.67
AAPL171.07-0.7800-0.45
GOOG1 111.348.88000.81
MSFT91.49-1.2300-1.33
XOM74.89-0.8600-1.14
WFC59.73-0.2200-0.37
JNJ129.91-0.9600-0.73
FB177.911.90001.08
GE14.49-0.2500-1.70
JPM115.190.48000.42
...

TickerPriceChg.%52 Week High
AAP114.008.21161.99
MAT17.023.3426.12
EXPD63.993.3367.54
MOS27.462.6233.59
PSA190.752.38232.21
VRSK99.232.26102.00
RHI57.572.2260.59
UTX129.262.21139.24
DLPH50.042.1960.39
AAL52.802.0959.08
SIG50.071.9577.94
CF42.631.9443.98
GPS32.221.9335.68
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 0.20
Current Ratio 0.40
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -7.30
Leverage Ratio -1.60
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-17.80
EBIT Margin-360.60
EBITDA Margin-348.20
Pre-tax Profit Margin-323.80
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 3.17
PS Ratios 0.00
Price to Cash Flow -
Price to Free Cash Flow 0.00
Cash Flow Per Share -67.41
Price to Tangible Book-0.04
Book Value per Share-30.44
Enterprise Value (in ths.)34 109
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)75.62
ROE last 12 Months 730.10
Return on Assets (5Y Avg) -100.67
ROA last 12 Months -123.85
Return on Capital (5Y Avg) -
ROC last 12 Months -17.17
Return on invested Capital Q -
Return on invested Capital Y-111.88
Assets Turnover0.20
Receivables Turnover3.10
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)8 021
Revenue per Share 390.79
Revenue Growth 3 Years -0.42
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q03 2017--17.20-
Q02 2017-18.40-20.80-13.04
Q01 2017-29.20-25.6012.33
Q04 2016-21.20-23.20-9.43
Q03 2016-40.00-29.2027.00
Q02 2016-1.18-1.0610.17
Q01 2016-1.16-1.28-10.34
Q04 2015-1.05-1.07-1.90
Earnings Per EndEstimateRevision %Trend
9/2017 QR-0.380.00-
12/2017 QR-0.370.00-
12/2017 FY-1.83-45.24Negative
12/2018 FY-0.3746.38Positive
Next Report Date5th Mar 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume296 534
Shares Outstanding (in ths.)880
Trades Count835
Dollar Volume388 517
Avg. Volume179 719
Avg. Weekly Volume721 216
Avg. Monthly Volume281 733
Avg. Quarterly Volume117 134

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

62%38%

Bearish Bullish

59%41%

Bearish Bullish

73%27%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
1 (33.33 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
2 (100.00 %)
2 (100.00 %)
2 (66.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Moderate Buy
2.33

There are no comments yet.

News

x